<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Kratom • MAHA</title>

  <!-- Fonts & base stylesheet -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;800&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="style.css?v=21">

  <!-- Mobile layout + image tweaks -->
  <style>
    .k-facts { display: grid; grid-template-columns: repeat(2, minmax(0,1fr)); gap: 14px; }
    .k-fact { display: flex; align-items: flex-start; gap: 10px; padding: 14px;
      background: rgba(255,255,255,.04); border:1px solid rgba(255,255,255,.12); border-radius:14px; }
    .k-fact svg { width: 24px; height: 24px; flex: 0 0 24px; opacity: .9; }
    .k-fact p { margin:0; word-break: normal; overflow-wrap: break-word; hyphens: auto; }
    @media (max-width: 760px){ .k-facts { grid-template-columns: 1fr !important; } }
    figure img { width:100%; height:auto; border-radius:10px; box-shadow:0 2px 6px rgba(0,0,0,.25); background:#121826; }
    figcaption { font-size:13px; color:var(--muted); margin-top:6px; }
  </style>
</head>
<body>
  <div class="container">
    <header>
      <div class="logo">
        <div class="logo-badge" aria-hidden="true"></div>
        <div class="brand">MAHA • Mothers Against Herbal Abuse</div>
      </div>
      <nav class="nav"><a href="index.html">Home</a></nav>
    </header>

    <!-- HERO -->
    <section class="hero">
      <h1 class="k-title">Kratom: What Parents Should Know</h1>
      <p class="k-sub">Mitragynine converts into 7-hydroxymitragynine (7-OH), a potent opioid receptor agonist. Despite “natural” marketing, kratom products can cause dependence, withdrawal, and even neonatal abstinence.</p>

      <div class="k-facts">
        <div class="k-fact">
          <p><b>Acts like an opioid.</b> 7-OH binds the same μ-opioid receptors as morphine. Human studies confirm measurable 7-OH after kratom use; animal work shows potency several times higher.<sup>1–4</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Rising harm reports.</b> CDC data show hundreds of kratom-positive overdose deaths. U.S. poison centers logged 10,272 kratom cases (2014–2023).<sup>5–7</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Dependence and withdrawal.</b> Clinicians document kratom dependence, opioid-like withdrawal, and neonatal abstinence in infants born to kratom-using mothers.<sup>8–11</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Unregulated and misleading.</b> Kratom products are often mislabeled or adulterated with synthetic drugs. FDA warns no kratom products are approved or proven safe.<sup>12–13</sup></p>
        </div>
      </div>

      <div class="k-actions">
        <a class="btn btn-primary" href="https://www.usa.gov/elected-officials" target="_blank" rel="noopener">Find my elected officials</a>
        <a class="btn" href="index.html#info">Back to Information Center</a>
      </div>
    </section>

    <!-- PARENT PLAYBOOK -->
    <section class="k-card">
      <h2 style="margin:0 0 8px">Parent Playbook</h2>
      <div class="k-facts">
        <div class="k-fact">
          <p><b>What to watch for.</b> Kratom powders, capsules, gummies, and drinks sold as “energy,” “relaxation,” or “herbal tea.” Symptoms: sweating, tremor, anxiety, vomiting, or cravings when stopped.<sup>5–9</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Where it’s sold.</b> Gas stations, vape shops, and online supplement stores. Bright, candy-like packaging often targets younger buyers.<sup>12–13</sup></p>
        </div>
        <div class="k-fact">
          <p><b>If someone is in trouble.</b> For extreme drowsiness, confusion, or seizure-like activity, call <b>911</b>. For guidance, contact <b>Poison Control: 1-800-222-1222</b>.<sup>6–7</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Talk about it.</b> “Just because it’s sold next to vitamins doesn’t mean it’s safe. Kratom acts on the same brain receptors as opioids. I care about your health — let’s read the real data together.”</p>
        </div>
      </div>
    </section>

    <!-- IMAGE CARD -->
    <section class="k-card">
      <h2 style="margin:0 0 8px">Packaging Example</h2>
      <p class="muted" style="margin-bottom:12px;">
        Kratom products often mimic candy and snack packaging, creating confusion and increasing risk of youth exposure.
      </p>

      <figure>
        <img src="IMG_0530.jpeg?v=1" alt="Kratom candy-like packaging (photo by MAHA)">
        <figcaption>Various Kratom products showing candy-like appearance. Photo © Mothers Against Herbal Abuse.</figcaption>
      </figure>
    </section>

    <!-- MYTHS VS FACTS -->
    <section class="k-card">
      <h2 style="margin:0 0 8px">Myths vs. Facts</h2>
      <div class="k-facts">
        <div class="k-fact">
          <p><b>Myth:</b> “It’s natural, so it’s safe.”<br>
             <b>Fact:</b> Morphine and heroin were “natural,” too. Natural origin doesn’t make a chemical safe for human use.<sup>1–4</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Myth:</b> “It helps with withdrawal.”<br>
             <b>Fact:</b> Clinical reports show kratom <i>causes</i> opioid-type dependence and withdrawal. No physician-guided tapering protocols exist.<sup>8–10</sup></p>
        </div>
        <div class="k-fact">
          <p><b>Myth:</b> “The FDA just hasn’t approved it yet.”<br>
             <b>Fact:</b> FDA has formally rejected kratom New Dietary Ingredient (NDI) applications citing safety and abuse risk.<sup>12–13</sup></p>
        </div>
      </div>
    </section>

    <!-- REFERENCES -->
    <section class="k-card">
      <h3 class="refs-title">References</h3>
      <div class="refs">
        <ol>
          <li>Kruegel AC, et&nbsp;al. 7-Hydroxymitragynine is an active metabolite of mitragynine. <i>ACS Cent Sci.</i> 2019;5(6):992–1001. <a href="https://pubs.acs.org/doi/10.1021/acscentsci.9b00141" target="_blank" rel="noopener">link</a></li>
          <li>Huestis MA, et&nbsp;al. Human mitragynine & 7-OH pharmacokinetics after kratom leaf. <i>Molecules.</i> 2024;29(5):984. <a href="https://www.mdpi.com/1420-3049/29/5/984" target="_blank" rel="noopener">link</a></li>
          <li>Hill R, et&nbsp;al. Respiratory depressant effects of mitragynine limited by conversion to 7-OH. <i>Br J Pharmacol.</i> 2022;179(14):3875–3885. <a href="https://doi.org/10.1111/bph.15832" target="_blank" rel="noopener">link</a></li>
          <li>Matsumoto K, et&nbsp;al. Antinociceptive effect of 7-OH in mice. <i>Life Sci.</i> 2004;74(17):2143–2155. <a href="https://pubmed.ncbi.nlm.nih.gov/14969718/" target="_blank" rel="noopener">link</a></li>
          <li>Matsumoto K, et&nbsp;al. μ-receptor involvement in 7-OH effects. <i>Eur J Pharmacol.</i> 2006;549(1–3):63–70. <a href="https://doi.org/10.1016/j.ejphar.2006.08.013" target="_blank" rel="noopener">link</a></li>
          <li>Olsen EOM, et&nbsp;al. Kratom detected in overdose deaths—27 states. <i>MMWR.</i> 2019;68(14):326–327. <a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6814a2.htm" target="_blank" rel="noopener">link</a></li>
          <li>CDC. SUDORS Final Data Dashboard (2020–2023). <a href="https://www.cdc.gov/overdose-prevention/data-research/facts-stats/sudors-dashboard-fatal-overdose-data.html" target="_blank" rel="noopener">link</a></li>
          <li>Gummin DD, et&nbsp;al. 2023 NPDS Annual Report. <i>Clin Toxicol (Phila).</i> 2024;62(12):e1–e1261. <a href="https://doi.org/10.1080/15563650.2024.2411302" target="_blank" rel="noopener">link</a></li>
          <li>Weiss ST, Douglas HE. Treating kratom withdrawal with buprenorphine/naloxone. <i>J Addict Med.</i> 2021;15(2):167–172. <a href="https://journals.lww.com/journaladdictionmedicine/Fulltext/2021/04000/Treatment_of_Kratom_Withdrawal_and_Dependence.9.aspx" target="_blank" rel="noopener">link</a></li>
          <li>Davidson L, et&nbsp;al. Neonatal abstinence after maternal kratom. <i>J Neonatal Perinat Med.</i> 2019;12(1):109–112. <a href="https://pubmed.ncbi.nlm.nih.gov/30149482/" target="_blank" rel="noopener">link</a></li>
          <li>Mackay L, Abrahams R. Maternal & neonatal dependence/withdrawal. <i>Can Fam Physician.</i> 2018;64(2):121–122. <a href="https://www.cfp.ca/content/64/2/121" target="_blank" rel="noopener">link</a></li>
          <li>Wright ME, et&nbsp;al. Systematic review of prenatal kratom exposure. <i>J Perinatol.</i> 2021;41:1236–1243. <a href="https://doi.org/10.1038/s41372-021-00952-8" target="_blank" rel="noopener">link</a></li>
          <li>Ordean A. Review & clinical management: antenatal kratom exposure. <i>Res Rep Neonatol.</i> 2023;13:15–21. <a href="https://doi.org/10.2147/RRN.S419864" target="_blank" rel="noopener">link</a></li>
          <li>U.S. FDA. FDA and Kratom — Public Health Focus (2025 update). <a href="https://www.fda.gov/news-events/public-health-focus/fda-and-kratom" target="_blank" rel="noopener">link</a></li>
        </ol>
      </div>
      <a class="back-link" href="index.html#info">← Back to Information Center</a>
    </section>

    <footer style="margin-top:18px; color:var(--muted);">
      © <span id="year"></span> MothersAgainstHerbalAbuse.org
    </footer>
  </div>

  <script src="main.js?v=21"></script>
</body>
</html>
